Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection.
about
Survivors Remorse: antibody-mediated protection against HIV-1.Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions.Immune-mediated thrombocytopenia in horses infected with equine infectious anemia virusThe cat and mouse of HIV-1 antibody escape.Evolution to predominance of swine influenza virus hemagglutinin mutants of predictable phenotype during single infections of the natural host.Tracking members of the simian immunodeficiency virus deltaB670 quasispecies population in vivo at single-cell resolution.Selection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horsesLentiviruses are etiological agents of chronic diseases in animals and acquired immunodeficiency syndrome in humans.The avian retrovirus env gene family: molecular analysis of host range and antigenic variantsSequence divergence and open regions of RNA secondary structures in the envelope regions of the 17 human immunodeficiency virus isolates.Enhanced sensitivity to neutralizing antibodies in a variant of equine infectious anemia virus is linked to amino acid substitutions in the surface unit envelope glycoprotein.Equine infectious anemia virus replication is upregulated during differentiation of blood monocytes from acutely infected horses.Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus.In vivo dynamics of equine infectious anemia viruses emerging during febrile episodes: insertions/duplications at the principal neutralizing domainEarly detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes.N-Glycans on the Nipah virus attachment glycoprotein modulate fusion and viral entry as they protect against antibody neutralizationNovel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected ponyMajor histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins.Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys.Protein interactions with DNA elements in variant equine infectious anemia virus enhancers and their impact on transcriptional activityCharacterization of the antigenic domains of the major core protein (p26) of equine infectious anemia virusAnalysis of equine humoral immune responses to the transmembrane envelope glycoprotein (gp45) of equine infectious anemia virusSelection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys.Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategiesDirect determination of the point mutation rate of a murine retrovirus.The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro.Wild-type equine infectious anemia virus replicates in vivo predominantly in tissue macrophages, not in peripheral blood monocytesEmergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees.Extreme heterogeneity in populations of vesicular stomatitis virusCharacterization of equine infectious anemia virus long terminal repeat.Course and extent of variation of equine infectious anemia virus during parallel persistent infections.Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies.Role of the host immune response in selection of equine infectious anemia virus variantsThe visna virus genome: evidence for a hypervariable site in the env gene and sequence homology among lentivirus envelope proteins.Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patientImpact of persistent Anaplasma marginale rickettsemia on tick infection and transmissionUnique p24 epitope marker to identify multiple human immunodeficiency virus variants in blood from the same individualsDevelopment, evaluation, and laboratory validation of immunoassays for the diagnosis of equine infectious anemia (EIA) using recombinant protein produced from a synthetic p26 gene of EIA virus.Adaptive immunity is the primary force driving selection of equine infectious anemia virus envelope SU variants during acute infection.An EIAV field isolate reveals much higher levels of subtype variability than currently reported for the equine lentivirus family.
P2860
Q30238730-FE55F20F-3E5E-477D-AF0E-F9C6ECDBEDA6Q30356755-27C166F5-9104-410B-BCB2-EC0BAD2DFFBBQ33373647-82EC6885-7481-42CA-B6F7-D6D64430F60EQ33504607-F04ED070-9915-4A36-89C7-A5D708A48932Q33662845-06ED0A18-89A5-4956-820B-EFAEE26118E9Q33781894-20462AA4-89A7-4351-A9A2-9E601A76B931Q33990657-35D6E726-56FB-48D4-A450-962379AB461FQ34081147-00814353-9200-4D4F-B006-DF2CAF799500Q34552390-1DBFF603-E48F-4118-A5D4-BDD5AE813204Q35224513-82F60455-458F-4215-8061-139639A24945Q35833979-90538753-B75F-413C-9887-9EB14A70F117Q35853921-5A6FE4D7-652F-441D-AAD1-0AD6831B800DQ35860883-4BEB63DC-1440-4095-8683-D02AAD0C9AF9Q35887752-EEC22D97-3C63-45A1-A105-0E453C1AF53FQ35929492-0E4D9340-3616-4EE2-A740-85B7D59B8790Q36363882-D3842ED1-3753-43EF-AE74-825E249BF013Q36549092-1CA4F9CD-285D-4E33-94CC-42015042DC2AQ36628637-5E9D6BD0-35FF-46E3-9CB7-884D1B8A0A85Q36650125-C31D12A1-6945-4FEF-A548-DDEBB4C7948FQ36654359-0A8FCB58-ED4C-4649-BD9B-1FD24AD0CFD3Q36680806-AC291C57-D8A2-4966-833F-37991CB09370Q36680833-09D46E45-68B0-4FDA-BC1F-E1E5876BF44FQ36683893-2B527707-B27A-4656-B94D-24622F735002Q36690394-61449717-204C-406A-8F56-2584EE1A103DQ36698163-3B3FD57B-02FF-4207-83D9-649A5098F22EQ36698743-59517119-394A-4859-BE98-39298C8323ABQ36702174-B30F2CBD-AAA2-486E-A597-869C59E4D5CDQ36812220-D910D776-C624-4FB8-AB16-ACBAA7FA66F9Q36827358-FDFFE597-6260-4798-8A27-0EFCD5297678Q36885415-0E4B15EC-5AC3-4269-B318-30F0473C3AFDQ36886882-5CE0FCBD-A36D-4C60-94F0-6565C858E746Q36919068-31443B3F-B509-4155-996B-0D89E9175581Q36919966-1998EC59-424B-488C-B431-D7CA4712061DQ36920774-758DDDB1-9ED5-47F7-AF60-AFC63DECE4D8Q37031589-702BCB49-2826-445E-BD57-E2DD13537775Q37131655-EA849425-DA01-4AFB-8A0F-AB38AD596C59Q37216630-E2D6B4C9-C28E-47AE-A058-B868791F546DQ37321505-EEFDE959-8F5B-4C39-AD22-7BE9391C4E2DQ37349055-56366EF2-A1B7-4D7F-B7F9-8929542156FCQ37405780-D207ADA4-EC98-472B-A0A8-C2D9BB8A2152
P2860
Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Rapid emergence of novel antig ...... s during persistent infection.
@en
type
label
Rapid emergence of novel antig ...... s during persistent infection.
@en
prefLabel
Rapid emergence of novel antig ...... s during persistent infection.
@en
P2093
P2860
P1433
P1476
Rapid emergence of novel antig ...... s during persistent infection.
@en
P2093
K A Hussain
K L Schnorr
O Salinovich
R C Montelaro
P2860
P407
P577
1986-01-01T00:00:00Z